{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:15:38Z","timestamp":1787501738570,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartfailure.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.hfc.2016.12.005","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T09:32:54Z","timestamp":1488879174000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Advanced Heart Failure Therapies for Cancer Therapeutics\u2013Related Cardiac Dysfunction"],"prefix":"10.1016","volume":"13","author":[{"given":"Christopher M.","family":"Bianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadeer G.","family":"Al-Kindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme H.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2016.12.005_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hfc.2016.12.005_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.clml.2015.07.638","article-title":"Trends and disparities in cardiovascular mortality among survivors of hodgkin lymphoma","volume":"15","author":"Al-Kindi","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.hfc.2016.12.005_bib3","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1200\/JCO.1996.14.12.3112","article-title":"Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer","volume":"14","author":"Venturini","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hfc.2016.12.005_bib4","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","article-title":"Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer","volume":"28","author":"Tukenova","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hfc.2016.12.005_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hfc.2016.12.005_bib6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/cncr.10854","article-title":"Trastuzumab-associated cardiotoxicity","volume":"95","author":"Keefe","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hfc.2016.12.005_bib7","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/1097-0142(19820615)49:12<2470::AID-CNCR2820491210>3.0.CO;2-Y","article-title":"Coronary heart disease mortality after irradiation for Hodgkin's disease","volume":"49","author":"Boivin","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.hfc.2016.12.005_bib8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a\u00a0report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2016.12.005_bib9","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2016.12.005_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mayocp.2015.09.009","article-title":"Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology","volume":"91","author":"Al-Kindi","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.hfc.2016.12.005_bib11","first-page":"246","article-title":"Onco-cardiology: the time has come","volume":"38","author":"Yeh","year":"2011","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.hfc.2016.12.005_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jacc.2013.09.040","article-title":"Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support)","volume":"63","author":"Oliveira","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2016.12.005_bib13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.amjcard.2012.10.048","article-title":"Heart transplant survival outcomes for adriamycin dilated cardiomyopathy","volume":"111","author":"Lenneman","year":"2013","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2016.12.005_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cardfail.2016.03.014","article-title":"Heart transplantation outcomes in radiation-induced restrictive cardiomyopathy","volume":"22","author":"Al-Kindi","year":"2016","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hfc.2016.12.005_bib15","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.athoracsur.2014.06.056","article-title":"Cardiac transplantation for radiation-induced cardiomyopathy: the Mayo Clinic experience","volume":"98","author":"Saxena","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hfc.2016.12.005_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ejechocard\/jer142","article-title":"Assessment of right ventricular functions during cancer chemotherapy","volume":"12","author":"Tanindi","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.hfc.2016.12.005_bib17","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.ijcard.2013.07.246","article-title":"Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: a prospective study using novel cardiac imaging and biochemical markers","volume":"168","author":"Grover","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2016.12.005_bib18","first-page":"609194","article-title":"Right ventricular dysfunction in patients experiencing cardiotoxicity during breast cancer therapy","volume":"2015","author":"Calleja","year":"2015","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.hfc.2016.12.005_bib19","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2013.01.019","article-title":"Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer","volume":"61","author":"Ylanen","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2016.12.005_bib20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.healun.2012.03.018","article-title":"Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation","volume":"31","author":"Oliveira","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2016.12.005_bib21","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.hrthm.2013.01.008","volume":"10","author":"Russo","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hfc.2016.12.005_bib22","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.cardfail.2016.06.171","article-title":"The use of cardiac resynchronization therapy in cancer patients with heart failure: preliminary findings in a comprehensive cancer center","volume":"22","author":"Fadol","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2016.12.005_bib23","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.amjcard.2007.12.037","article-title":"Usefulness of cardiac resynchronization therapy in the management of Doxorubicin-induced cardiomyopathy","volume":"101","author":"Ajijola","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2016.12.005_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2009.10.024","article-title":"Usefulness of cardiac resynchronization therapy in patients with Adriamycin-induced cardiomyopathy","volume":"105","author":"Rickard","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2016.12.005_bib25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0041-1345(96)00310-7","article-title":"Heart transplantation for doxorubicin-induced congestive heart failure in children and adolescents","volume":"29","author":"Musci","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hfc.2016.12.005_bib26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jtcvs.2008.09.021","article-title":"Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device","volume":"137","author":"Fitzpatrick","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hfc.2016.12.005_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11886-015-0570-3","article-title":"Advanced heart failure due to cancer therapy","volume":"17","author":"Shah","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hfc.2016.12.005_bib28","first-page":"232607","article-title":"Orthotopic heart transplantation and mechanical circulatory support in cancer survivors: challenges and outcomes","volume":"2015","author":"Ghosh","year":"2015","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.hfc.2016.12.005_bib29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pbc.20485","article-title":"Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation","volume":"46","author":"Haddy","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.hfc.2016.12.005_bib30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.healun.2016.01.019","article-title":"A\u00a0multicenter study of the HeartWare ventricular assist device in small children","volume":"35","author":"Miera","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2016.12.005_bib31","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.healun.2014.08.010","article-title":"Virtual implantation evaluation of the total artificial heart and compatibility: beyond standard fit criteria","volume":"33","author":"Moore","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2016.12.005_bib32","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.113.001435","article-title":"Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study","volume":"127","author":"Wu","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2016.12.005_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtcvs.2006.09.041","article-title":"Cardiac surgery after mediastinal radiation: extent of exposure influences outcome","volume":"133","author":"Chang","year":"2007","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hfc.2016.12.005_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.109.858076","article-title":"Selection of cardiac transplantation candidates in 2010","volume":"122","author":"Mancini","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2016.12.005_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hfc.2016.12.005_bib36","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.cardfail.2015.06.198","article-title":"Increased risk\u00a0of cerebrovascular death in patients with chemotherapy-induced cardiomyopathy","volume":"21","author":"Mehanna","year":"2015","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2016.12.005_bib37","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1161\/STROKEAHA.112.658625","article-title":"Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology","volume":"43","author":"Schwarzbach","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.hfc.2016.12.005_bib38","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.healun.2012.09.018","article-title":"Outcomes of adults with restrictive cardiomyopathy after heart transplantation","volume":"31","author":"DePasquale","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713616301660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713616301660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T15:51:34Z","timestamp":1535989894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713616301660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1551713616301660"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2016.12.005","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced Heart Failure Therapies for Cancer Therapeutics\u2013Related Cardiac Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}